Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-525-2 | CAS number: 7173-51-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2004
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3700 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- Didecyldimethylammonium chloride
- EC Number:
- 230-525-2
- EC Name:
- Didecyldimethylammonium chloride
- Cas Number:
- 7173-51-5
- Molecular formula:
- C22H48N Cl
- IUPAC Name:
- didecyldimethylammonium chloride
- Details on test material:
- IUCLID4 Test substance: as prescribed by 1. 2 as typical marketed substance (act: 40%, water: 60%)
Composition: ca. 40% Didecyldimethylammonium chloride (CASno.: 7173-51-5) in water only. batchno: WIR03048
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or test system and environmental conditions:
- Species: Rabbit
Strain: KBL New Zealand White, Specific Pathogen Free (S.P.F.).
Source: Charles River Laboratories (Elevage Scientifique des Dombes, Châtillon-sur-Chalaronne, France).
Sex: Female
Age/weight at study initiation: 18-20 weeks; mean body weight of 3494 g (range: 3105 g to 3940 g).
Number of animals per group: 22
The animals were individually housed in stainless steel cages, in a barriered rabbit unit, under specific pathogen free (SPF) standard laboratory
conditions: temperature : 18 ± 3°C; relative humidity : 50 ± 20%; light/dark cycle : 8h dark/16h light (5:00 - 21:00);
ventilation : about 8 to 10 cycles/hour of filtered, non-recycled air.
Control animals: Yes
Mating period: Were mated at the breeder's facilities. The day of confirmed mating (visual assessment) was designated as day 0 post-coitum (p.c.) or day 0 of gestation (GD 0). The animals were supplied to CIT on day 1 post-coitum; consequently they were acclimated for a period of 5 days before
the beginning of the treatment period.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- Administration/ Exposure: Oral
Duration of exposure Rabbit: day 6-28 of gestation
Postexposure period: None, as exposure period was until day prior to term.
Type: oral gavage
Concentration Gavage; 0, 4, 12 or 32 mg DDAC/kg bw . The choice of the dose-levels was based on a preliminary study of effects on embryo-fetal
development in rabbits (CIT/Study No. 26153 RSL), in which the test item, DDAC, was administered to pregnant female rabbits, from day 6 to day
28 of pregnancy at the dose-levels of 4, 16 or 32 mg DDAC/kg/day.
Vehicle: Aqueous solution with purified water.
Concentration in vehicle: 0, 1.33, 4, 10.66 mg/mL. The test item dosage forms were prepared daily and stored at room temperature prior to use.
Chemical analysis of DDAC in dosage form: The concentration of samples taken from each control and test item dosage form prepared for use on
the first day of treatment and on the last day of treatment was determined. Values were found to be in agreement with nominal concentration ± 10%.
Total volume applied: 3 mL/kg BW/day
Controls: Vehicle - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- At the start and at end of the study.
- Details on mating procedure:
- Females were mated at breeder's facilities and the day of confirmed mating was designated as Day 0.
- Duration of treatment / exposure:
- Day 6 to 28 post coitum
- Frequency of treatment:
- Daily
- Duration of test:
- 24 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Gavage 0, 4, 12 or 32 mg a.i./kg bw/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 22
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Groups of 22 mated female KBL New Zealan White rabbits were gavaged the test substance at 4, 12 and 32 mg/kg/day from day 6 to day 28 post coitum. One group of 22 mated females received the vehicle alone. Clinical sign and mortality were checked daily. Bosy weight and food consumption were recorded at designated intervals. On day 29 post coitum, the does were sacrificed and subjected to macroscopic examination of the major organs. The gravid uterus was weighed. The fetuses removed and litter parameters were examined. The fetuses were then weighed and subjected to external and internal tissue, organs and bone examination.
Examinations
- Maternal examinations:
- Refer to study design
- Ovaries and uterine content:
- Refer to study design
- Fetal examinations:
- Refer to study design
- Statistics:
- Refer to study design
- Indices:
- Refer to study design
- Historical control data:
- Refer to study design
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
In absence of a dose-related increase of death/abortion at 4 and 12 mg DDAC/kg/day and with the abortion of one female in the control group, the mortality at 4 and 12 mg DDAC/kg/day were considered to be most probably incidental and not related to treatment with the test item. 32 mg DDAC mg/kg/day, death/abortion in 3 females were ascribed to the treatment with the test item. When given 12 mg DDAC/kg/day, colored urine and loud breathing was observed in one female from GD 22 each. Both animals however, showed no findings at autopsy. At 32 mg DDAC/kg/day, the number of animals showing clinical signs was greater than in the control group, and most of these clinical signs (colored urine, soft feces, soiled urogenital area) were recorded at the end of the gestation period, along with an absence of feces observed for three animals. Presence of blood in the bedding was noted in two females on GD 16 or 22 and one female showed an emaciated appearance on GD 29. No other clinical signs were considered to be treatment-related; absence of feces is commonly recorded at the end of pregnancy and was therefore not considered to be treatment-related at 4 mg DDAC/kg/day. Overall, there seems to be a dose related effect, tending to lower body weights at higher dose levels which corresponding to lower food consumption related to palatability of the compound in the diet.
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 4 mg/kg bw/day
- Based on:
- act. ingr.
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
There is a big variability in litter data. The low dose group shows higher number of dead fetuses, post implantation loss and lower fetal weight compared to control. On the other hand, the number of live fetuses is even higher than of control. At the mid-dose group comparable to control again. The high-dose group of 32 mg DDAC/kg/d resulted to an increased post-implantation loss, decrease in live fetuses with a decreased fetal body weight, and high number of dead fetuses. Upon examination of the soft tissue, presence of whitish fluid in the abdomens of 5/6 fetuses (one litter) was observed. No relevant malformations or variations were observed during the fetal evaluation. At lower concentrations, litter parameters were not affected by the test treatment and no evidence of treatment-related findings were noted at skeletal examinations of the fetuses.
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 12 mg/kg bw/day
- Based on:
- act. ingr.
- Sex:
- male/female
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Key result
- Abnormalities:
- not specified
Overall developmental toxicity
- Key result
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Result: no specific concerns for developmental toxicity by DDAC.
In absence of a dose-related increase of death/abortion at 4
and 12 mg DDAC/kg/day and with the abortion of one female in
the control group, the mortality at 4 and 12 mg DDAC/kg/day
were considered to be most probably incidental and not
related to treatment with the test item. 32 mg DDAC
mg/kg/day, death/abortion in 3 females were ascribed to the
treatment with the test item.
When given 12 mg DDAC/kg/day, colored urine and loud
breathing was observed in one female from GD 22 each. Both
animals however, showed no findings at autopsy.
At 32 mg DDAC/kg/day, the number of animals showing clinical
signs was greater than in the control group, and most of
these clinical signs (colored urine, soft feces, soiled
urogenital area) were recorded at the end of the gestation
period, along with an absence of feces observed for three
animals. Presence of blood in the bedding was noted in two
females on GD 16 or 22 and one female showed an emaciated
appearance on GD 29. No other clinical signs were considered
to be treatment-related; absence of feces is commonly
recorded at the end of pregnancy and was therefore not
considered to be treatment-related at 4 mg DDAC/kg/day.
Overall, there seems to be a dose related effect, tending to
lower body weights at higher dose levels which corresponding
to lower food consumption related to palatability of the
compound in the diet.
There is a big variability in litter data. The low dose
group shows higher number of dead fetuses, post implantation
loss and lower fetal weight compared to control. On the
other hand, the number of live fetuses is even higher than
of control. At the mid-dose group comparable to control
again. The high-dose group of 32 mg DDAC/kg/d resulted to an
increased post-implantation loss, decrease in live fetuses
with a decreased fetal body weight, and high number of dead
fetuses.
Upon examination of the soft tissue, presence of whitish
fluid in the abdomens of 5/6 fetuses (one litter) was
observed. No relevant malformations or variations were
observed during the fetal evaluation.
At lower concentrations, litter parameters were not affected
by the test treatment and no evidence of treatment-related
findings were noted at skeletal examinations of the fetuses.
Applicant's summary and conclusion
- Conclusions:
- Based on the results of this study, there are no specific concerns for developmental toxicity by DDAC.
- Executive summary:
A study was conducted in rabbits according to OECD Guideline and 414 and EPA OPPTS guideline to determine the prenatal developmental toxicity of the test substance. Groups of 22 mated female KBL New Zealand White rabbits were gavaged the test substance at 4, 12 and 32 mg/kg/day from day 6 to day 28post coitum. One group of 22 mated females received the vehicle alone. Clinical sign and mortality were checked daily. Body weight and food consumption were recorded at designated intervals. On day 29 post coitum, the does were sacrificed and subjected to macroscopic examination of the major organs. The gravid uterus was weighed. The foetuses removed and litter parameters were examined. The foetuses were then weighed and subjected to external and internal tissue, organs and bone examination. Based on the results of this study, there are no specific concerns for developmental toxicity by DDAC. LO(A)EL maternal toxic effects: 32 mg a.i./kg bw/day resulted from clear signs of maternal toxicity (mortality, abortion, clinical signs, body weight loss, increased incidence autopsy findings). At 12 mg/kg bw/day, one female displayed coloured urine and another female loud breathing, each from GD 22. There is no real critical effect, but more a general display of toxicity, possibly related to reduced food intake due to palatability. Based on this, the LOAEL could be set at 12 mg a.i./kg bw/day. NO(A)EL maternal = 4 mg/kg bw/day. LO(A)EL embryotoxic/teratogenic effects: 32 mg DDAC/kg/day. Effects observed are increased number of dead fetuses, lower number of live foetuses, increased post-implantation loss and a decreased foetal body weight. 5/6 foetuses had whitish fluid in the abdomens upon soft tissue examination. NO(A)EL embryotoxic / teratogenic effects = 12 mg a.i./kg bw/day
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.